Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $1.58 in the prior trading day, Altamira Therapeutics Ltd (NASDAQ: CYTO) closed at $1.44, down -8.86%. In other words, the price has decreased by -$8.86 from its previous closing price. On the day, 2.98 million shares were traded. CYTO stock price reached its highest trading level at $1.6 during the session, while it also had its lowest trading level at $1.4.
Ratios:
Our goal is to gain a better understanding of CYTO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.27 and its Current Ratio is at 0.32.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYTO now has a Market Capitalization of 3539592 and an Enterprise Value of 2708202.
Stock Price History:
Over the past 52 weeks, CYTO has reached a high of $28.40, while it has fallen to a 52-week low of $1.38. The 50-Day Moving Average of the stock is -22.77%, while the 200-Day Moving Average is calculated to be -65.69%.
Shares Statistics:
The stock has traded on average 1.18M shares per day over the past 3-months and 375600 shares per day over the last 10 days, according to various share statistics. A total of 2.24M shares are outstanding, with a floating share count of 2.24M. Insiders hold about 0.06% of the company’s shares, while institutions hold 0.34% stake in the company. Shares short for CYTO as of 1711584000 were 444464 with a Short Ratio of 0.38, compared to 1709164800 on 56584. Therefore, it implies a Short% of Shares Outstanding of 444464 and a Short% of Float of 24.200001.
